非小细胞肺癌的向疗法:现在和未来
Jessica McLaughlin1, Jonathan Berkman2, Patrick Nana-Sinkam1
1Department of Internal Medicine, Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University Health System, Richmond, VA 23298.
肺癌的治疗方法随着向疗法和免疫疗法的发展而进步. 对抗药机制的进一步研究对于开发个性化肺癌疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 医学科学 医学科学 医学科学
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 近几十年来,肺癌治疗方法取得了重大进展.
- 分子异质性推动了向治疗的发展.
研究的目的:
- 审查针对非小细胞肺癌的向治疗的演变.
- 讨论新出现的对当前治疗方法的耐药性模式.
- 概述个性化肺癌治疗的未来方向.
主要方法:
- 在非小细胞肺癌中针对性治疗的文献综述.
- 分析免疫疗法和辐射疗法的最新进展.
- 检查治疗阻力背后的分子机制.
主要成果:
- 针对性疗法改善了特定肺癌分子亚型的治疗结果.
- 免疫疗法和先进的辐射技术提供了新的治疗途径.
- 了解耐药机制是克服治疗局限性的关键.
结论:
- 个性化肺癌治疗已经被有针对性的疗法彻底改变.
- 对抗性机制的持续研究对于未来的治疗开发至关重要.
- 未来的战略将专注于克服耐药性,以改善患者的生存率.
更多相关视频
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
